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Abstract
Background: Viola canescens Wall. ex. Roxb. exhibits analgesic, antimalarial and antispasmodic activities. It is
used folklorically for the treatment of liver diseases, hypertension, malaria and cancer. The current study
investigates phytochemical constituents, antioxidant and hepatoprotective activity of solvent extracts of
whole plant of Viola canescens.
Methods: Phytochemicals, acute toxicity study and antioxidant activity of Viola canescens methanolic extract (VCME),
ethyl acetate fraction (EAF), and partially purified EAF (90% EAF and combination of 80% EAF + 20% methanol fraction
(EAF +Me) was carried out. Hepatoprotective activity of VCME, EAF (200 and 400 mg/kg body weight) and partially
purified EAF (50 mg/kg body weight) was investigated in carbon tetrachloride (CCl4) intoxicated BALB/c mice for 7
days. Membrane stabilization effect was determined by hypotonic solution induced hemolysis while DNA ladder assay
was carried out by polyacrylamide gel electrophoresis.
Results: Phytochemical screening of VCME showed the presence of alkaloids, phenols, flavonoids, saponins,
carbohydrates, tannins and triterpenes. VCME, EAF (at 200 and 400 mg/kg body weight) and partially purified EAF (90%
EAF and EAF +Me) at 50 mg/kg body weight significantly reduced the level of ALT, ALP, total bilirubin and restored
the level of serum protein in comparison to CCl4 treated group. A significant reduction in malondialdehyde (MDA) and
elevation in catalase (CAT) and superoxide dismutase (SOD) level was observed in extract treated animals as compared
to CCl4 (p < 0.05). The IC50 values in membrane stabilization potential for VCME, EAF and sodium salicylate were 3.7 ± 0.
11, 3.4 ± 0.15 and 3.2 ± 0.09 mg/ml, respectively. Similarly, CCl4 induced degradation of DNA was counteracted by
VCME and EAF. The liver biopsy of mice treated with the solvent extracts showed remarkable restoration of normal
histological archeitecture.
Conclusions: Viola canescens showed significant hepatoprotective potential due to its antioxidant and membrane
stabilization effect.
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Background
Liver exposure to drugs, toxic chemicals and environmental
pollutants results in the formation of reactive oxygen
species (ROS) that are retained responsible, at least in
part, for hepatitis, cirrhosis, hepatic cancer and many
other disorders [1]. The carbon tetrachloride (CCl4)
induced hepatotoxicity in rodents resembles the viral
hepatotoxicity in humans which renders it a suitable
model for hepatoprotective drugs development [2]. In
liver, CCl4 results in formation of free radicals such
as trichloromethyl and trichloromethylperoxyl radicals
that bind to macromolecules such as DNA, lipids and
proteins [3]. These free radicals extract hydrogen atoms
from the lipid membrane of hepatocytes to form lipid
hydroperoxides which ultimately leads to liver necrosis
[4, 5]. The increased level of lipid hydroperoxides and
free radicals cause reduction in the level of antioxidant
enzymes, along with oxidative DNA damage, genetic mu-
tation, chromosomal alteration and low CYP2E1 activity.
Inbuilt antioxidant defense system of hepatocytes consists
of catalase, superoxide dismutase, glutathione system, as-
corbic acid and tocopherol that provide protection against
free radical mediated damage [6, 7]. Oxidative stress,
occuring due to imbalance between antioxidant defence
system and ROS production, is involved in the patho-
physiological changes associated with various liver disor-
ders such as hepatitis, hepatocellular carcinoma and liver
cirrhosis [8]. Therefore an insight into the role of oxidative
stress and antioxidants in liver ailments may help in the
development of natural and more effective drugs. Now
days, antioxidants from natural sources are increasingly
being used in liver diseases and about 50% of drugs used
in liver diseases are, either, natural products or their deriv-
atives [9].
The currently used synthetic drugs for the treatment
of hepatic disorders are inadequate and have severe
adverse reaction [10, 11]. Silymarin, a hepatoprotective
drug from Silybum marianum, consist of silybin, isosily-
bin, silydianin, silychristin and taxifolin, is associated
with the drawback of poor solubility and low bioavailabil-
ity [12–16]. There is an intense need to search for and
develop more efficient hepatoprotective drugs with better
solubility, high bioavailability, economical and safe.
Medicinal plants are enriched with polyphenols and
flavonoids that have the potential to terminate free radi-
cals, improve the level of antioxidant enzymes, modulate
gene expression and hence provide protection against
ROS [17, 18]. Family Violaceae comprise of 20 genera
and 800 species while in Pakistan one genus (Viola) and
17 species of this family are reported [19]. Compounds
isolated from Viola include flavonoids, phenylpropa-
noids, terpenoids, amides, sterols, essential oils, saccha-
rides, aromatic acids and cyclotides. Viola has exhibited
a number of activities such as antioxidant, antibacterial,
anti-inflammatory, immunomodulatory, antimalarial,
anticancer, insecticidal, anti-HIV, anxiolytic, anticonvul-
sant, cytotoxic, hepatoprotective and lung protective
activity [20]. Viola odorata exhibited hepatoprotective
activity against paracetamol induced hepatotoxicity due to
the presence of flavonoids (isorhamnetin and luteolin)
[21–23]. Similarly, during preliminary phytochemical
investigation of the Viola canescens, polyphenols and
flavonoids, beside saponins, triterpenes and alkaloids
[24–26] were found to be present in appreciable amount
dictating its possible role as an effective hepatoprotectant.
V. canescens has exhibited antimalarial, analgesic and
antispasmodic activity [27, 28]. This plant has also been
reported for its use in liver disorders [29, 30], in addition
to hypertension [31], eczema, malaria, rheumatism, gastric
acidity, dysentery, respiratory tract problems, pyrexia, epi-
lepsy and cancer [32] in traditional medicines. Keeping in
view the folkloric use beside flavonoids and polyphenolic
contents of Viola canescens and their well established role
in combating oxidative stress as well as hepatotoxicity, the
current study was designed to investigate antioxidant
and hepatoprotective potential of Viola canescens as




DPPH, acrylamide, bisacrylamide, thiobarbituric acid, tet-
ramethoxy propane (Sigma Aldrich), methanol, n-hexane,
chloroform, ethyl acetate (commercial grade), diclofenac
sodium (Novartis), phenobarbital sodium (Swan Pharma,
Islamabad Pakistan), Tween 80, gallic acid (BDH), for-
malin (Scharlu), xylene, trichloroacetic acid, carbon
tetrachloride, ascorbic acid, Folin Ciocalteau reagent,
TLC cards, silica (Merck), silymarin (Zhejiang Chemicals
Hangzhou, China), enzymatic kits such as ALT, ALP, total
bilirubin, total protein (Vitro scientific, Germany), DNA
ladder, ethidium bromide (Thermo Fisher Scientific).
Plant material
Viola canescens was collected from Dir Upper, Khyber
Pakhtunkhwa Pakistan in March 2013 and authenticated
by Professor Dr. Muhammad Ibrar, from Department of
Botany University of Peshawar. The specimen was
submitted to the herbarium, University of Malakand
under reference number H.UOM.BG. 209. The fresh
plant was cleaned, dried in shade, powdered, weighed
(3 kg), subsequently soaked in 80% methanol (10 L,
three times) for 15 days and then filtered [33]. The
filtrate was concentrated at 40 °C in rotary evaporator to
obtain a semisolid residue of methanolic extract of Viola
canescens (VCME) having percentage yield of 9.3%
(280 g). VCME was further subjected to fractionation
resulting in n-hexane fraction (NHF) with yield of 2.33%
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(70 g), chloroform fraction (CF) 0.83% (25 g), ethyl acet-
ate fraction (EAF) 1.6% (48 g), butanol fraction (BTF)
1.06% (32 g) and aqueous fraction (AQF) 2.8% (84 g).
Partial purification of ethyl acetate fraction
EAF was subjected to partial purification over silica gel
through column chromatography. The optimum solvent
system for column chromatography was determined by
TLC. EAF was loaded into glass column by slurry
method and eluted with 4 l of each of these solvents;
100% n-hexane, followed by n-hexane-ethyl acetate in
ratio of 90:10, 80:20, 70:30, 50:50, 40:60, 30:70, 10:90
(90% EAF) and then 100% ethyl acetate. Successive
fractions were collected and concentrated in rotary evap-
orator at 40 °C. Afterwards, the column was eluted with
methanol: ethyl acetate in ratio of 5:95, 10:90, 15:85,
20:80 and finally washed with 100% methanol [34, 35].
TLC was carried out with hexane: ethyl acetate (3:7).
Fractions having same retardation factor (Rf ) were com-
piled for further analysis.
Phytochemical investigation
VCME was investigated by qualitative tests for carbo-
hydrates, saponins, steroids, flavonoids, triterpenes, tannins,
alkaloids, proteins, fixed oils and fats according to proce-
dures described by Harborne [36].
Total phenolic content
Calibration curve for gallic acid was constructed at
20–100 μg/ml. Afterwards, 1 ml extract in distilled water
(0.1 g/100 ml) was added to 5 ml Folin Ciocalteau reagent
(1: 10 aqua) and 4 ml sodium carbonate (7.5%), mixed and
incubated at room temperature for 30 min followed
by absorbance determination at 765 nm by spectro-
photometer (Thermoscientific, USA) against blank.
Total phenolic content (GAE/g) was calculated from
the calibration curve [37].
Total flavonoid content
Total flavonoid content was determined as mentioned in
literature [38]. Extracts (0.3 ml), methanol (3.4 ml, 30%)
aluminium chloride (0.15 ml, 0.3 M) and sodium nitrite
(0.15 ml, 0.5 M) were mixed in a test tube. After 5 min
sodium hydroxide (1 ml, 1 M) was added to the mixture
followed by absorbance determination at 506 nm by
spectrophotometer (Thermoscientific, USA) against
blank. Calibration curve for standard (Quercitin) was
constructed at 5–100 mg/l. The quantity of total flavo-
noids was determined from the standard curve as mg of
quercitin equivalent per g (QE/g).
Antioxidant activity
DPPH assay
The antioxidant activity of the solvent extracts of the plant
and the standard was determined by DPPH method [39].
Methanolic solution of plant extracts and ascorbic acid
were prepared at 31.25, 62.5, 125, 250 and 500 μg/ml.
Methanolic solution of DPPH (20 μg/ml, 1 ml) was mixed
with 1 ml of standard and sample solution. The resultant
solutions were kept in dark for 30 min at room
temperature and absorbance was measured at 517 nm by
UV-visible spectrophotometer.
Hydrogen peroxide assay
H2O2 scavenging activity was performed as mentioned
in literature [40]. H2O2 solution (0.6 ml, 40 mM) in
phosphate buffer (pH 7.4) was mixed with extracts
(31.25 to 500 μg/ml). After 10 min, absorbance of H2O2
was determined against blank at 230 nm. Percent H2O2
scavenging and IC50 of extracts and standard (alpha
tocopherol) were calculated.
Experimental animals
BALB/c mice of 20–30 g were obtained from NIH
Islamabad, Pakistan and housed in the stainless steel
cages in the animal house, University of Malakand main-
tained on standard diet, free access to water and food,
with 12 h dark and light cycle.
Acute toxicity study
Acute toxicity study was carried out according to the
guidelines of Organization for Economic Cooperation
and Development 423 [41]. Healthy mice were randomly
assigned into five groups (n = 6) and fasted overnight
prior to experiment. Group I was administered Tween
80. Extracts were dissolved in Tween 80 and adminis-
tered to group II-V as a single dose of 250, 500, 1000
and 2000 mg/kg body weight of VCME, EAF, 90% EAF
and EAF +Me (80% EAF + 20% Methanol) fraction p.o.,
followed by observation for toxicity and behavioral
changes at 30 min and then 2,4, 8, 24 and 48 h.
Hepatoprotective activity
Direct method
BALB/c mice were divided into nine groups (n = 6) [42].
Group I received liquid paraffin 0.8 ml/kg, i.p, which
was used as vehicle for CCl4. Group II mice were treated
with CCl4 i.p (30%, 0.8 ml/kg). Group III was adminis-
tered CCl4 (0.8 ml/kg i.p) plus silymarin 100 mg/kg p.o.
Similarly, group IV-VII were orally administered with
VCME and EAF at 200 and 400 mg/kg respectively for 7
consecutive days. While groups VIII-IX were adminis-
tered partially purified EAF (90% EAF and EAF +Me
(80% ethyl acetate + 20% methanol) at 50 mg/kg. All ani-
mals, except group I, were administered CCl4 at 0.8 ml/
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kg i.p for 7 days. Blood was collected from all mice by
cardiac puncture after 24 h of the last dose administra-
tion, under diethyl ether anesthesia, followed by laparat-
omy and liver removal. All the animals were weighed
before and after experimental period for changes in body
weight.
Indirect method (Phenobarbital-induced sleep model)
Phenobarbital induced sleeping method was performed
as mentioned in literature [43]. The experiment was de-
signed as mentioned before. On the 7th day, all the mice
were administered phenobarbital sodium (40 mg/kg i.p)
followed by determination of the time between the loss
and regain of righting reflex (sleeping time).
Assessment of hepatoprotection
Biochemical investigation
Collected blood was centrifuged at 1000 rpm for 10 min
for serum separation that was subsequently used for
estimation of ALT, ALP, total bilirubin and total protein
as per established methods using commercially available
enzymatic kits (Vitro scientific, Germany).
Estimation of antioxidant enzymes
The liver was removed carefully, weighed (1 g) and
homogenized in 10 ml of ice-cold phosphate buffer
(50 mM, pH 7.4).
Activity of catalase activity was determined according
to already mentioned protocol [44]. Briefly, 3 ml of reac-
tion mixture consist of 1.9 ml buffer (pH 7.0), 1 ml of
the H2O2 and 0.1 ml of liver homogenate. The activity
was determined from the change in absorbance at
240 nm in UV–visible spectrophotometer. The activity
was presented as unit of H2O2/mg of tissue.
For superoxide dismutase activity determination,
sodium carbonate buffer (2.8 ml, 0.05 mM) and 0.1 ml
of liver homogenate were incubated at 30 °C for 45 min.
Afterwards, adrenaline solution (10 μL, 9 mM) was
added and the absorbance was determined at 480 nm
against blank. The results were reported as unit of SOD
activity/mg of tissue [45].
Lipid peroxidation
The liver homogenate (0.1 ml) was added to
trichloroacetic acid (2.0 ml, 20%), mixed and centrifuged
at 4000 rpm for 20 min. The obtained supernatant (2 ml)
was added to thiobarbituric acid reagent (2 ml). Standard
(tetramethoxypropane) (5–20 nmoles) and blank were
also prepared in the same way. The mixtures were incu-
bated on water bath at 100 °C for 20 min followed by
absorbance determination at 532 nm in UV–visible spec-
trophotometer. The lipid peroxide contents were reported
as moles MDA per 100 mg of protein [46].
Membrane stabilization potential
Membrane stabilization potential of VCME and EAF
was determined by hypotonic solution induced human
erythrocyte haemolytic assay as per previously published
protocol [47]. Healthy human volunteers who have not
taken NSAIDs prior to the experiment were used in the
study. Collected blood (5 ml) was centrifuged at
2500 rpm for 5 min followed by removal of supernatant.
Isotonic buffer was used to wash the cell suspension
until the supernatant appeared clear. Erythrocyte sus-
pension (40% v/v) was made with isotonic buffer and
50 μl of the cell suspension was mixed with 1.0 ml of
hypotonic buffer and 100 μl of the solvent extracts. After
20 min incubation at room temperature the samples
were centrifuged (5000 rpm, 5 min), supernatant was
separated and its absorbance determined at 540 nm. So-
dium salicylate was used as reference. Percent inhibition
of erythrocyte haemolysis by the extracts and standard
was calculated as
% Inhibition of haemolysis ¼ ODc– ODs=ODc  100
Where ODc is absorbance of control and ODs is absorb-
ance of sample. The concentration needed to inhibit
50% of erythrocytes lysis as compare to the control
(IC50) was calculated from the dose response curves.
DNA isolation and ladder assay
DNA isolation from hepatic tissue was carried out accord-
ing to previously reported method [48]. The tissue was
homogenized in 1 ml of lysis buffer [0.15 M NaCl, 20 mM
Tris-Cl (pH 7.5), 1 mM EDTA, 1 mM EGTA, 1% Triton
X-100 and 25 mM disodium pyrophosphate] at 37 °C for
1 h. Afterwards, 0.4 ml of saturated sodium chloride was
added to cell lysates followed by incubation on ice for
5 min and centrifugation at 3000 rpm for 30 min. Chilled
ethanol was used to precipitate the DNA that was sepa-
rated through centrifugation. DNA washing was carried
out with 70% ethanol followed by drying and then resus-
pended in Tris-EDTA buffer followed by quantification.
Same amount of sample DNA and standard DNA ladder
were loaded on 30% polyacrylamide gel containing
ethidium bromide. Electrophoresis was carried out for
Table 1 Total phenolic and flavonoid content of Viola canescens




VCME 87.5 ± 0.06 59 ± 0.13
NHF 27.5 ± 0.04 22 ± 0.16
CF 92.5 ± 0.02 76 ± 0.09
EAF 107.5 ± 0.14 80 ± 0.25
BTF 77.5 ± 0.09 72 ± 0.18
AQF 52.5 ± 0.13 45 ± 0.06
Abdullah et al. BMC Complementary and Alternative Medicine  (2017) 17:10 Page 4 of 11
90 min at 100 volts, and DNA was observed under UV-
transilluminator and photographed.
Histopathological study
The liver was fixed in 10% neutral buffered formalin for
24 h, followed by dehydration in different concentrations
of alcohol and xylene, embedded in paraffin wax, subse-
quently sectioned with microtome (4 μm), stained with
hematoxylin and eosin (H&E) and observed under light
microscope and photomicrographs were taken [49].
The liver sections were scored according to previously
reported protocol [50].
Statistical analysis
Statistical analyses were performed by SPSS version 16
(SPSS Inc. Chicago IL, USA). All the data are reported
as a mean of 6 animals per group ± SEM. Statistical
analyses were conducted by one way ANOVA followed
by post hoc Tukey test for multiple comparisons. All the
values of p < 0.05 were considered significant.
Results
Phytochemical investigation
The results of phytochemical investigation show the
presence of carbohydrates, alkaloids, phenols, flavonoids,
saponins, tannins and triterpenes with no proteins, fixed
oils, fats and steroids.
Total phenol content
Total phenol content of methanol extract and different
fractions is presented in Table 1. EAF had highest
phenol content (107.5 ± 0.14 mg GAE/g) followed by CF
(92.5 ± 0.09 mg GAE/g), VCME (87.5 ± 0.13), BTF
(77.5 ± 0.06), AQF (52.5 ± 0.02) while the least quan-
tity was found in NHF (27.5 ± 0.04 mg GAE/g). The
descending order of phenol content was EAF > CF >
VCME > BTF > AQF > NHF.
Total flavonoid content
Total flavonoids content is shown in Table 1. EAF
had maximum flavonoids content (80 ± 0.25 mg QE/g)
Fig. 2 Hydrogen peroxide scavenging assay of Viola canescens
Fig. 1 DPPH assay of Viola canescens
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followed by CF (76 ± 0.09), BTF (72 ± 0.18), VCME
(59 ± 0.13), AQF (45 ± 0.06), while NHF had the least
amount (22 ± 0.04 mg QE/g). The descending order of




EAF +Me exhibited highest DPPH scavenging effect
(86.89 ± 0.16%, IC50 = 12 μg/ml), followed by 90% EAF
(84.5 ± 0.04%, IC50 = 14 μg/ml), while EAF had DPPH
radical scavenging activity (83.7 ± 0.26%, IC50 = 15 μg/ml),
and for VCME (78.6 ± 0.10, IC50 = 26 μg/ml) (Fig. 1).
Hydrogen peroxide scavenging potential
The partially purified EAF exhibited better scavenging
action as compared to other fractions (Fig. 2). IC50 for
H2O2 scavenging was 4, 5, 7, 25, 15, μg/ml for Ascorbic
acid, EAF +Me, 90% EAF, VCME and EAF respectively.
Acute toxicity
Oral administration of the solvent extracts up to
2000 mg/kg body weight did not produce toxicity as
evident from lack of diarrhea, drowsiness, convulsions,
writhing, respiratory distress and mortality.
Hepatoprotective activity
The serum level of ALP, ALT and total bilirubin was
significantly elevated and total protein declined by CCl4
administration (Table 2). VCME caused significant
reduction in level of ALT, ALP, total bilirubin and eleva-
tion in total protein level in comparison to the CCl4
treated group (p < 0.05). Furthermore, EAF reduced the
ALT level from 195.6 ± 1.49 to 59.66 ± 0.88 at 400 mg/kg
as compare to silymarin (p > 0.05). Group administered
with silymarin 100 mg/kg p.o decreased ALT level
from 195.6 ± 1.49 to 54.5 ± 1.17 as compared to nor-
mal (p > 0.05). Likewise, among the partially purified
fractions, EAF +Me exhibited optimum hepatoprotec-
tion at 50 mg/kg as compared to silymarin in terms
of decline of ALT from 195.67 ± 1.49 to 50.66 ± 1.76 and
total bilirubin from 2.74 ± 0.077 to 0.7 ± 0.05 (p > 0.05).
While 90% EAF resulted in decrease of ALT from
195.67 ± 1.49 to 76.33 ± 6.35 (p < 0.05) and total bilirubin
from 2.74 ± 0.077 to 0.813 ± 0.06 (p > 0.05) as compared
to silymarin. Similarly, total protein level was improved by







Normal 40.24 ± 0.73*** 53.42 ± 1.12*** 14.8 ± 0.72***
CCl4 15.87 ± 0.24 18.3 ± 0.95 43.5 ± 0.45
Silymarin 38.7 ± 0.4 52.65 ± 2.1 16.8 ± 0.06
VCME 200 22.2 ± 0.11 29.81 ± 2.34 34.3 ± 0.13
VCME 400 27.5 ± 0.15 32.45 ± 0.55 26.1 ± 0.2
EAF 200 34.4 ± 0.9 40.37 ± 0.66 17.5 ± 0.42***
EAF 400 39.76 ± 0.53*** 51.88 ± 1.18*** 16.2 ± 0.55***
90% EAF 39.93 ± 0.16*** 52.12 ± 0.55*** 15.4 ± 0.09***
EAF+ Me 40.17 ± 0.08*** 53.3 ± 0.28*** 15.1 ± 0.1***
***Values are significantly different as compared to CCl4 p > 0.05
Table 2 Effect on liver biomarkers
ALT (U/L) ALP (U/L) T.B (mg/dl) T.P (g/dl)
Normal 48.16 ± 1.6 176.8 ± 2.1 0.76 ± 0.01 5.09 ± 0.18
CCl4 195.60 ± 1.4 315.3 ± 1.7 2.73 ± 0.07 3.91 ± 0.47
Silymarin 54.50 ± 1.17 190.6 ± 2.2 0.89 ± 0.01 4.77 ± 0.37
VCME 200 93.00 ± 1.15*** 250.8 ± 2.7*** 1.32 ± 0.02*** 4.18 ± 0.21
VCME 400 85.30 ± 1.11*** 239.1 ± 1.2*** 1.23 ± 0.01*** 4.25 ± 0.14
EAF 200 74.16 ± 1.22*** 208.6 ± 1.2*** 1.06 ± 0.03*** 4.4 ± 0.12
EAF 400 59.66 ± 0.88 ns 195.3 ± 1.6 ns 0.99 ± 0.01 ns 4.61 ± 0.18***
90% EAF 76.33 ± 0.73*** 193.0 ± 1.08 ns 0.83 ± 0.08 ns 4.75 ± 0.42***
EAF+ Me 50.67 ± 0.44 ns 187.0 ± 0.68 ns 0.70 ± 0.05 ns 4.78 ± 0.25***
***p < 0.05 as compare to standard
ns p > 0.05 as compare to standard











Normal 23.91 ± 1.22 26.26 ± 0.80 9.8 1.735 ± 0.16 6.60
CCl4 24.04 ± 0.80 22.71 ± 0.48 −5.5 1.84 ± 0.175 8.10
Silymarin 24.48 ± 0.34 25.42 ± 0.30 3.83 1.69 ± 0.045 6.65
VCME 200 22.97 ± 0.64 22.49 ± 0.70 −2.08 1.64 ± 0.19 7.30
VCME 400 22.16 ± 0.53 22.51 ± 0.11 1.57 1.66 ± 0.42 7.38
EAF 200 25.80 ± 0.84 26.92 ± 1.10 0.46 1.70 ± 0.14 6.31
EAF 400 23.55 ± 0.22 24.72 ± 0.33 4.9 1.72 ± 0.40 6.95
90% EAF 24.230 ± 0.27 26.86 ± 0.375 4.6 1.72 ± 0.19 6.4
EAF+ Me 23.87 ± 1.68 25.43 ± 1.88 6.5 1.73 ± 0.11 6.8
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administration of VCME, EAF and more significantly
elevated by partially purified EAF as shown in Table 2.
Antioxidant enzymes
The activities of catalase and superoxide dismutase were
significantly reduced by CCl4 as compared to corre-
sponding control group. Their level was improved by
VCME, EAF and partially purified EAF (Table 3).
Lipid peroxidation
MDA level was enhanced by CCl4 administration as com-
pare to control. Co-administration of VCME and ethyl
acetate fractions to CCl4-treated mice resulted in partial
recovery of MDA. The high dose of extracts (400 mg/kg)
was more effective as compare to low dose (200 mg/kg)
(Table 3). Moreover, partially purified EAF resulted in near
to normal level of MDA.
Effect on body and liver weight
Significant loss in body weight (−5.5 ± 6.845%) was
observed in the CCl4 intoxicated group as compared to
normal during the study period. There was gain in body
weight due to administration of EAF (4.9 ± 4.4%) and
partially purified ethyl acetate fractions, EAF +Me
(6.5 ± 0.782%) and 90% EAF (4.6 ± 0.488%) which is
comparable to silymarin (p > 0.05). Moreover, CCl4
administration resulted in gain of liver weight which
was successfully countered by EAF and partially purified
EAF (90% EAF and EAF +Me). There was insignificant
difference between liver weights of mice administered
with EAF as compare to silymarin (p > 0.05) as shown in
Table 4.
Phenobarbital induced sleeping time
CCl4 induced prolongation of phenobarbital sleeping
time (PST) as compare to normal group; however
administration of VCME, EAF reduced sleeping time as
compare to silymarin (Tables 5 and 6). Furthermore,
90% EAF and EAF +ME had more efficient reduction of
PST that signifies its better hepatoprotective activity.
Membrane stabilization potential
VCME and EAF resulted in stabilization of RBC mem-
brane. The membrane stabilizing effect of EAF was
higher as compare to VCME which is in agreement with
biochemical study. The IC50 values for VCME, EAF and
sodium salicylate were 3.7 ± 0.11, 3.4 ± 0.15 and 3.2 ±
0.09 mg/ml (Fig. 3).
DNA ladder assay
Protective effect of VCME and EAF on CCl4 induced
DNA damage in the liver tissue of mice is shown by
DNA ladder assay (Fig. 4). Extensive DNA breaking in
hepatic tissue was observed in mice administered with
CCl4. Concurrent administration of silymarin, VCME
and EAF protected the DNA from damage showing
hepatoprotective effect of Viola canescens.
Histopathological observations
Histological specimens of liver for control, CCl4, sily-
marin (100 mg/kg), EAF, partially purified EAF (90%
EAF and EAF +Me) are shown in Fig. 5a-f. Mice adminis-
tered with CCl4 showed extensive hepatocyte necrosis, se-
vere fatty changes, sinusoidal congestion and lymphocytic
infiltration as shown in Fig. 5b. VCME demonstrated
moderate fatty changes accompanied by mild necrosis and
infiltration. Liver sections of ethyl acetate and partially
purified EAF administered mice showed significant recov-
ery from necrosis, fatty changes, sinusoid congestion and
Table 6 Histopathological effects of Viola canescens
Groups/Observations Fatty changes Centrilobular necrosis Piecemeal necrosis Congestion in sinusoids Lymphocyte infiltration
Control - - - - -
CCl4 +++ ++++ +++ +++ +++
Silymarin + - - - +
VCME ++ + + + +
EAF + - - - +
90% EAF - - - + +
EAF +Me - - - + -
-, absent; +, mild; ++, moderate; +++, severe; ++++, extremely severe
Table 5 Effect on phenobarbital induced sleeping time in mice
S. No Group Sleeping duration (minutes) % recovery
1 Control 85 ± 2.26 —
2 CCl4 130 ± 3.88 ——
3 Silymarin 100 98 ± 1.36*** 71.11
4 VCME 200 115 ± 0.92*** 33.33
5 VCME 400 108 ± 0.88 48.88
6 EAF 200 101 ± 1.46 64.44
7 EAF 400 97 ± 0.93*** 73.33
8 90% EAF 98 ± 1.06*** 71.11
9 EAF+ Me 96 ± 1.15*** 75.55
Values are means ± S.E.M, n = 6
***p < 0.001 as compare to CCl4 group
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lymphocytic infiltrations which is comparable to normal
and in correlation with the biochemical tests.
Effects of Viola canescens extract on living conditions
of mice
General observations during the study period showed that
CCl4 intoxicated mice exhibited anorexia, fur in a mess,
poor activity and weight loss. These effects were reversed
to a great extent by administration of Viola canescens.
Discussion
The natural antioxidants reduce oxidative stress mediated
damage and help prevent hepatotoxicity, carcinogenesis,
mutagenesis and aging due to their radical termination
potential. Moreover Viola canescens is enriched with phe-
nols and flavonoids which are strong antioxidants [51, 52].
Oxidative stress is involved in a number of hepatic disor-
ders that is one of the serious health problems across the
globe [53]. Natural antioxidants eliminate oxidative stress
caused by CCl4 and other hepatotoxicant [54]. The
available synthetic antioxidants have some serious adverse
reactions. The quest to discover natural antioxidants
which are cost effective and have no/few adverse effects
has become a challenge for scientists over the last decades.
The current study involves investigation of total phe-
nols and flavonoid contents, and the possible mech-
anism of antioxidant and hepatoprotective activity of
Viola canescens.
DPPH and hydrogen peroxide radical scavenging
assays are important tools for the assessment of antioxi-
dant potential of extracts [55]. In DPPH assay, radical
scavenging potential of V. canescens extracts may be
attributed to a direct role in trapping free radicals by
donating electron or hydrogen atom. Moreover, hydro-
gen peroxide is involved in generation of hydroxyl
radicals, which cause further damage to the cells [56].
Therefore, it is important to search for more effective
antioxidant compounds which exhibit good radical
termination potential for ROS.
Carbon tetrachloride is bioactivated by cytochrome
p450 enzymes resulting in the formation of free radicals
that attack polyunsaturated fatty acids to generate
peroxy and alkoxy radicals that, in turn, forms highly
reactive lipid peroxides. The lipid peroxide formation
cause loss of cell membrane integrity, leakage of
enzymes, DNA damage, and hepatocyte necrosis [57].
Hepatocellular damage causes the leakage of liver
biomarkers into serum. Enhanced ALT level shows loss
of functional integrity of hepatocytes [58]. CCl4 also
impairs bile flow with consequent increase in ALP and
bilirubin level which are excreted through bile. VCME
and its fractions restored the ALP and bilirubin level by
Fig. 4 Effect on DNA by polyacrylamide gel electrophoresis
Fig. 3 Membrane stabilization potential
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membrane stabilization and prevention of biliary dys-
function. CCl4 also affect the protein synthesis in liver
leading to decrease serum protein levels. VCME protects
liver and restores its synthetic and metabolic function.
Catalase and SOD are the key antioxidant enzymes
which play a major role in oxidative damage against oxi-
dative stress induced by free radicals. The current study
showed that carbon tetrachloride administration in mice
results in decrease activities of CAT and SOD which is
in corroboration with other investigations [59, 60]. CCl4
cause lipid peroxidation and increases the level MDA in
hepatocytes. MDA, the secondary product of the lipid
peroxidation, is an important indicator of tissue damages
[61]. Administration of solvent extracts of V. canescens
markedly decreased the MDA content near to normal as
was revealed by other plant extracts [59, 60].
Lipid peroxidation product react with DNA to form
mutagenic pirimedopurinone adduct of deoxyguanosine
(M1G). Free radicals attack nucleic acids and cause
oxidative damage to DNA and chromosomal alteration.
In the current study, CCl4 degraded the DNA of mice
liver tissue by free radicals formation [59, 62]. Co-
administration of the solvent extracts appreciably re-
duced the DNA damage as shown by bands pattern in
DNA ladder assay. Similar results were obtained in an-
other study on the nephroprotective effects of Kombucha
tea against CCl4 induced oxidative stress in rats [63].
Phenobarbital is mainly metabolised by cytochrome
p450 enzyme system of the liver. An agent which inhibit
cytochrome p450 enzyme will increase duration of pheno-
barbital induced sleeping time (PST) and vice versa. In
case of CCl4 induced hepatotoxicity, prolongation of PST
Fig. 5 a Light micrograph of liver of normal mice (H&E). b Light micrograph of liver of CCl4 intoxicated mice (H&E). c Light micrographs of liver
of silymarin administered mice (H&E). d Light micrograph of liver of EAF administered mice (H&E). e Light micrograph of liver of 90% EAF administered
mice (H&E). f Light micrograph of liver of EAF+ Me administered mice (H&E)
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occurs due to destruction of the enzyme system. In the
current study the shortening of PST observed after
administration of VCME and its fractions show the ability
of extract to improve metabolic function of liver.
RBC membrane is analogous to lysosomal membrane.
Therefore, plant extracts which stabilize membrane of
lysosomes means that it diminishes the leakage of
lysosomal enzymes from activated neutrophils into sur-
rounding tissue. NSAIDs may either inhibit lysosomal
enzymes or stabilize the lysosomal membrane [47]. In a
similar way RBC membrane is stabilized by VCME and
EAF. Therefore,Viola canescence provides significant hepa-
toprotection by stabilization of hepatocyte membranes and
limits the release of transaminase into the serum.
In toxicological experiments, comparison of changes
in organ weight of animals is considered a sensitive
indicator of drug toxicity [64, 65]. A significant differ-
ence in body weight between CCl4 intoxicated animals
and extract administered groups was observed. The loss
in body weight was significantly reduced by administra-
tion of EAF and partially purified EAF (90% EAF and
80% EAF + 20% Me) as compare to silymarin (p > 0.05).
Similarly, the administration of EAF and partially puri-
fied EAF resulted in decrease of liver weight as compare
to silymarin (p > 0.05).
The histological examination of liver specimens
strongly supports the protective effect of Viola canescens
solvent extracts. CCl4 administration resulted in fatty
changes, sinusoidal congestion and piecemeal necrosis
with loss of cellular archeitecture. The oral administra-
tion of EAF and partially purified EAF showed remark-
able restoration of normal histological pattern of liver
having optimum results as compared to silymarin.
Conclusion
It may be concluded from the current study that hepato-
protective activity of Viola canescens is likely due to free
radical scavenging, membrane stabilization potential and
protection of endogenous antioxidant defense system.
Further investigation to isolate and purify the active
constituents responsible for hepatoprotection needs to
be carried out. Findings of this study are expected to
play a vital role in the development of new and effective
hepatoprotective remedy.
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